NDC 60687-252-46 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60687-252
- Requested NDC
- 60687-252-46
- Package NDCs from labels
- 60687-252-40, 60687-252-46, 60687-252-86
- Manufacturer
- American Health Packaging
- Effective date
- 2026-06-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - American Health Packaging | American Health Packaging | 2026-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-252-40 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 10 | |
| 60687-252-46 | Ondansetron | 10 in 1 TRAY | SOLUTION | 10 | 10 | |
| 60687-252-86 | Ondansetron | 3 in 1 CASE | SOLUTION | 3 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-252-40 | ML - Milliliter | 60687-252 | fff1e0d4-f8fc-41ab-9408-bee8420c5db1 | 1 | 2019-02-13 |
| 60687-252-46 | ML - Milliliter | 60687-252 | f339fc5c-dfb6-4593-83b5-71e2ea605b09 | 1 | 2019-02-13 |
| 60687-252-86 | ML - Milliliter | 60687-252 | 29cfca47-9dfd-4852-9f12-f8fb32ce50a3 | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HZ-Chord | BAPTISIA TINCTORIA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, HYDROCOTYLE ASIATICA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MEZEREUM, MORBILLINUM, NUX VOMICA, PALOONDO, PHYTOLACCA DECANDRA, SEPIA, THUJA OCCIDENTALIS, THYROIDINUM (BOVINE) | Energetix Corporation | 9685aec5-a65d-40fe-b5d7-2f13a69733bc | 2025-12-17 | Warnings | XF417D3PSL |
| Category V | IMMUNE SYSTEM BOOSTER | Vitality Works, Inc, | 0d3dd923-336c-4ccd-a344-ec49b2e80d10 | 2025-12-17 | Warnings | XF417D3PSL |
| STERILE CORD BLOOD COLLECTION UNIT (MSC123D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE | Maco Productions | e3b456ec-4578-485f-a696-8a343505f30b | 2025-12-16 | Warnings | 1Q73Q2JULR |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | QPharma, Inc. | fbe71308-2927-2467-e053-6394a90aa419 | 2025-12-16 | Warnings, Adverse reactions | NMH84OZK2B |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | QPharma, Inc. | 2fa30bdb-f60e-40a7-98b4-c346bc85d539 | 2025-12-15 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | QPharma, Inc. | dafe875e-391f-47a2-97b7-89840a760e44 | 2025-12-15 | Warnings, Adverse reactions | NMH84OZK2B |
| ElixirLidoFast Rapid Relief | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | ELIXIR HEALTHCARE USA, LLC. | 45de9dfa-6c89-1eae-e063-6294a90a4dac | 2025-12-13 | Warnings | PDC6A3C0OX |
| Kroger Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Kroger Company | 45b2dd86-7fb0-07bf-e063-6394a90a1884 | 2025-12-11 | Warnings | PDC6A3C0OX |
| FCS HP | EPINEPHRINE,GLUTAMICACID,MUCUNAPRURIENSSEED,NIACINAMIDE,SEROTONIN,UBIDECARENONE,CORTICOTROPIN,ADENOSINETRIPHOSPHATE,INSULINPORK,SUSSCROFAPARATHYROIDGLAND,SUSSCROFAPITUITARYGLAND,THIAMINEHYDROCHLORIDE,THYROID,ANHYDROUSCITRICACID,HERRINGSPERMDNA,SACCHAROMYCESCEREVISIAERNA,ANACARDIUMOCCIDENTALEFRUIT,ARSENICTRIOXIDE,ASPARTICACID,BARIUMCARBONATE,OYSTERSHELLCALCIUMCARBONATECRUDE,CLEMATISRECTAFLOWERINGTOP,LYCOPODIUMCLAVATUMSPORE,ANEMONEPULSATILLA,DATURASTRAMONIUM,SULFUR | Natural Creations, Inc. | ba8fed68-f27f-4651-adec-0994a5375887 | 2025-12-10 | Warnings | XF417D3PSL |
| FCS CP | CORTICOTROPIN,GLUTAMICACID,MUCUNAPURIENSSEED,SEROTONIN,EPINEPHRINE,NIACINAMIDE,UBIDECARENONE,ADENOSINETRIPHOSPHATE,INSULINPORK,SUSSCROFAPARATHYROIDGLAND,SUSSCROFAPITUITARYGLAND,THIAMINEHYDROCHLORIDE,THYROID,UNSPECIFIED,ANHYDROUSCITRICACID,HERRINGSPERMDNA,SACCHAROMYCESCEREVISIAERNA,ANACARDIUMOCCIDENTALEFRUIT,ARSENICTRIOXIDE,ASPARTICACID,BARIUMCARBONATE,OYSTERSHELLCALCIUMCARBONATE,CRUDE,CLEMATISRECTAFLOWERINGTOP,LYCOPODIUMCLAVATUMSPORE,ANEMONEPULSATILLA,DATURASTRAMONIUM,SULFUR | Natural Creations, Inc | cb69e9d6-62a6-4af0-8d2d-1e68b0830a20 | 2025-12-10 | Warnings | XF417D3PSL |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| PaxLyte | LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULE | Jaymac Pharmaceuticals | f520b130-61b3-443e-aaf6-91e094e7a334 | 2025-12-08 | Warnings, Adverse reactions | 1Q73Q2JULR |
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | d20768fe-4516-483a-a082-ff1df9ad1d99 | 2025-12-06 | Warnings, Adverse reactions | OJ245FE5EU |
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | XF417D3PSL |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | XF417D3PSL |
| Ondansetron | ONDANSETRON | Hospira, Inc. | e0862c02-781f-4b10-ae50-9c9c4ca26f6d | 2025-12-01 | Warnings, Adverse reactions | NMH84OZK2B |
| BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK | BUTYLENE GLYCOL, GLYCERIN, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT | BUDDATE Co Ltd | 464988ad-557e-13f5-e054-00144ff8d46c | 2025-11-30 | Warnings | PDC6A3C0OX |
| BUDDATE LOTUS MOISTURE ESSENCE | GLYCERIN, NIACINAMIDE, NELUMBO NUCIFERA FLOWER EXTRACT, PORTULACA OLERACEA EXTRACT | BUDDATE Co Ltd | 46499995-8b13-3e5c-e054-00144ff88e88 | 2025-11-30 | Warnings | PDC6A3C0OX |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | 1Q73Q2JULR XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.